6 Dosell are Implemented in a New Municipality

3 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / April 1, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that the partner Careium…

Love Hemp Group PLC Announces Response to the Latest FSA Novel Foods Update

3 years ago

LONDON, UK / ACCESSWIRE / April 1, 2022 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF), the brand-led consumer goods company focussed…

Angle PLC Announces Identifying Drug Targets in Cancer Metastasis

3 years ago

PARSORTIX SYSTEM DEMONSTRATES ABILITY TO ISOLATE CTCs FOR DOWNSTREAM MOLECULAR ANALYSIS, IDENTIFYING KEY DRUG TARGETS INVOLVED IN CANCER METASTASISWorld-class research…

Relief Therapeutics Announces that its Subsidiary was Issued a Swiss Patent Entitled ‘Vasoactive Intestinal Peptide (VIP) for the Use in the Treatment of Drug-induced Pneumonitis’

3 years ago

GENEVA, SWITZERLAND / ACCESSWIRE / April 1, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief "), a biopharmaceutical company…

Spexis Publishes Invitation to Annual General Meeting 2022

3 years ago

Ad hoc announcement pursuant to Art. 53 LR- Pre-AGM information call on April 7, 2022 at 2:30PM CET- AGM to…

Relief Reports that its U.S. Collaboration Partner has Announced that the I-SPY COVID Trial Suggests No Clinical Benefit with Addition of Nebulized Aviptadil in Critically Ill Patients with COVID-19

3 years ago

GENEVA, SWITZERLAND / ACCESSWIRE / April 1, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief "), a biopharmaceutical company…

XPhyto Closes First Tranche of Financing

3 years ago

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / March 31, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company")…

Mycrodose Therapeutics Announces First Clinical Candidate for Ketamine-Based Drug Delivery Device for Oral Mucositis

3 years ago

San Diego, California--(Newsfile Corp. - March 31, 2022) - Mycrodose Therapeutics ("Mycrodose"), a leading US pharmaceutical company specializing in the…

Pulse Biosciences Reports Fourth Quarter & Full Year 2021 Financial Results

3 years ago

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™…

Global Launch of New Ultra-Portable Fundus Camera, from epipole, at Vision Expo East (NYC)

3 years ago

epiCam: the power of desktop retinal imaging, in the palm of your hand NEW YORK, March 31, 2022 /PRNewswire/ -- epipole,…